ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Administrative Data"

  • Abstract Number: 1002 • ACR Convergence 2020

    Prostate Cancer Risk Is Not Increased in Rheumatoid Arthritis After Accounting for Retention in a Health Care System

    Kaitlyn Brittan1, Punyasha Roul1, Joshua Baker2, Yangyuna Yang1, Brian Sauer3, Namrata Singh4, Harlan Sayles1, Grant Cannon5, Ted Mikuls1 and Bryant England1, 1University of Nebraska Medical Center, Omaha, NE, 2University of Pennsylvania, Philadelphia, PA, 3University of Utah, Omaha, NE, 4University of Washington, Bellevue, WA, 5Salt Lake City VA Medical Center and University of Utah, Salt Lake City

    Background/Purpose: Patients with rheumatoid arthritis (RA) may have up to a 15% increased risk of prostate cancer per a recent meta-analysis (Simon et al. Arthritis…
  • Abstract Number: 0392 • ACR Convergence 2020

    Prevalence and Survival of Systemic Sclerosis (SSc) and Associated Interstitial Lung Disease (ILD) in Ontario, Canada over 10 Years

    Janet Pope1, Kobina Quansah2, Martin Kolb3, Jason Flavin4, Hassan Shazia5 and Soo Jin Seung5, 1Department of Medicine, University of Western Ontario, St. Joseph's Health Centre, London, ON, Canada, 2Boehringer Ingelheim (Canada) Limited, Burlington, ON, Canada, 3McMaster University and Firestone Institute for Respiratory Health, St Joseph's Healthcare, Hamliton, ON, Canada, 4Boehringer Ingelheim, Corporate Headquarters, Burlington, ON, Canada, 5HOPE Research Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada

    Background/Purpose: Systemic sclerosis (SSc) is an autoimmune disease characterized by skin thickening, vascular lesions and fibrotic changes in various organs, mainly the lungs, heart, intestinal…
  • Abstract Number: 1004 • ACR Convergence 2020

    The Incidence, Mortality, and Economic Burden of Potentially Preventable Infections in Rheumatoid Arthritis Patients

    Soumyasri Kambhatla1, Estefania Gauto-Mariotti2 and Augustine Manadan3, 1John H Stroger Hospital of Cook County, Riverside, IL, 2John H. Stroger Jr. Hospital of Cook County, Chicago, IL, 3Rush University Medical Center, Chicago, IL

    Background/Purpose: Streptococcus pneumoniae, Herpes zoster, and influenza infections are common and potentially preventable causes of morbidity and mortality. Vaccinations have been shown to reduce infection…
  • Abstract Number: 0400 • ACR Convergence 2020

    Outcomes of Systemic Sclerosis Hospitalizations by Hospital Teaching Status: Analysis of the National Inpatient Sample

    Ehizogie Edigin1, Precious Eseaton2 and Pius Ojemolon3, 1John H Stroger Jr. Hospital of Cook County, Chicago, IL, 2University of Benin Teaching Hospital, Benin, 3St. George's University, St. George's, Grenada

    Background/Purpose: Systemic sclerosis (SSc) is a chronic autoimmune connective tissue disease that results in hospitalizations in different hospital settings. It is unclear if outcomes of…
  • Abstract Number: 1012 • ACR Convergence 2020

    The Global Prevalence of Rheumatoid Arthritis: A Meta-Analysis

    Khalid Almutairi1, Johannes Nossent1, David Preen1, Helen Keen1 and Charles Inderjeeth1, 1The University of Western Australia, Perth, Western Australia, Australia

    Background/Purpose: To determine the global population prevalence of rheumatoid arthritis (RA) based on published studies and assess factors that influence RA prevalence estimates.Methods: Four electronic…
  • Abstract Number: 0477 • ACR Convergence 2020

    Rheumatology Fellowship Program Directors in the United States: Analysis of Demographics, Educational and Scholarly Achievements

    Aakanksha Khanna1, Dawid Czarny2, Vibhor Wadhwa3 and Alysia Kwiatkowski4, 1Department of Medicine, University at Buffalo, Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY, 2University at Buffalo, Amherst, NY, 3Department of Radiology, University of Arkansas for Medical Sciences, Little Rock, AR, 4State University of New York at Buffalo, Clarence, NY

    Background/Purpose: Rheumatology program directors (PDs) play a vital role in developing, improving and overseeing the fellowship programs. Although PDs have an important role to play…
  • Abstract Number: 1014 • ACR Convergence 2020

    Disease Modifying Anti-rheumatic Drugs, Biologics and Corticosteroid Use in Older Patients with Rheumatoid Arthritis over 20 Years

    John Hanly1 and Lynn Lethbridge2, 1Dalhousie University, Halifax, NS, Canada, 2Dalhousie University, Halifax, Canada

    Background/Purpose: The objective of the current study was to examine the change in prescribing patterns for older adults with RA over a 20 year period…
  • « Previous Page
  • 1
  • …
  • 11
  • 12
  • 13
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology